A series of hydrogenated ferulic acid amide derivatives 4 were synthesized. The molecular structures of the synthesized compounds were analyzed by 1 H NMR and HRMS. The biological activity study showed that some of them displayed excellent protection activity and curative activity against TMV at 500 g/mL.
Introduction
Viruses are among the most agriculturally important groups of plant pathogens, causing serious economic losses in many major crops by reducing yield and quality [1] . Although plant viruses are genetically rather simple, they are difficult to prevent or control and have devastating impact on crop growth. So, plant virus is often referred to as "plant cancer" for several reasons. It is reported that three class pesticides are discovered. For example, nucleoside medicines as ribavirin, tiazofurin, selenazofurin, and benzamide riboside, nonnucleosides such as dufulin and mycophenolic acid, and natural product as ningnanmycin can inhibit virus replication effectively and suppress virus symptoms.
Ferulic acid is isolated from many staple foods, such as fruits, vegetables, cereals, and coffee. It and its derivatives exhibited diversity activity, such as anticancer [2, 3] , antiatherogenic [4] , anticarcinogenic [5] , and antibacterial agents [6] , as well as anti-inflammatory activity [7, 8] . In view of these facts mentioned earlier, and also as a part of our work on the synthesis of bioactive lead compounds for drug discovery, the title compounds were designed. We herein report a series of hydrogenated ferulic acid amide derivatives 4 that have been found to possess potent antiviral activities.
Results and Discussion
2.1. Chemistry. All of the hydrogenated ferulic acid amide derivatives were prepared from a key intermediate hydrogenated ethyl ferulate, which was easily prepared by catalytic hydrogenation of the ferulic acid 1 using Pd/C and H 2 (1 atm), as shown in Scheme 1. Traditional methods of synthesis of amide suffer from disadvantages, such as long reaction time and inconvenience of handling. In this paper, an eco-friendly and high-yielding method for hydrogenated ferulic acid amides 3 from hydrogenated ethyl ferulate 2 and substituted 2-amino-1-phenylethanol was applied. It can be obtained under microwave irradiation at 130 ∘ C in freesolvent conditions for 30 min in generally good yields. As was mentioned earlier, alkylation of the compounds 3 yielded the compounds 4 followed by alkylation with bromoalkane to give the N-(2-alkoxy-2-phenylethyl) hydrogenated ferulic acid amide derivatives 4.
Spectrum. In the
1 H NMR spectra of title compounds, the NH proton signals of title compounds were appeared at 5.81 ∼ 6.02 ppm. All the alkyl or aryl groups showed the normal location. All the title compounds of HRMS matched with the theoretical values. Table 1 . The results showed that title compounds exhibited varying degrees of activities against TMV. Compound 4g displayed good protection activity (22.8%) at 500 g/mL, which is the same of ribavirin at 500 g/mL (32.6%). Compounds 4a and 4f showed the same curative activity level (24.2% and 28.9%, resp.) as ribavirin at 500 g/mL (32.6%).
Experimental

Materials and Methods.
1 H NMR spectra were measured on a Bruker AC-P500 instrument using TMS as an internal standard and CDCl 3 as solvent. Melting points were determined on an X-4 binocular microscope melting point apparatus (Beijing Tech Instruments Co., Beijing, China) and were uncorrected. HRMS were recorded on an IonSpec 7.0 T Fourier Transform Ion Cyclotron Resonance (FTICR) Mass Spectrometer. All chemicals or reagents were purchased from standard commercial suppliers.
Synthesis.
All of the hydrogenated ferulic acid amide derivatives were prepared as shown in Scheme 1.
To a solution of 3-(3,4-dimethoxyphenyl)acrylic acid (15 g, 72 mmol) in ethyl acetate (150 mL) and ethanol (150 mL), Pd/C (1.5 g, 10%) was added under the N 2 atmosphere. The mixture was refluxed for 72 h. After the reaction was completed, the Pd/C was filtered, and the solvent was evaporated. The combined organic phases were washed with brine, dried over MgSO 4 , and evaporated to afford white solid, yield 92%, m.p. 92-94 ∘ C (ref. 96-97 ∘ C). To a solution of 3-(3,4-dimethoxyphenyl)propanoic acid (1.44 g, 6.84 mmol) in THF under −20 ∘ C, isobutyl chloroformate (0.89 g, 6.84 mmol) and NMM (0.7 g, 7.18 mmol) were added. The mixture was stirred for 30 min. A solution of 2-amino-1-(4-nitrophenyl)ethanol (7.18 mmol) in THF was dropwise in the mixture, then it was stirred for 12 h at room temperature. After the reaction was completed, the THF was evaporated, and the residue was diluted with water and extracted several times with dichloromethane. The combined organic phases were washed with brine, dried over MgSO 4 , and evaporated. The remainder was purified by chromatography on silica gel using petroleum ether (60-90 ∘ C) and ethyl acetate as the eluent to afford compound 3. RX (7.56 mmol) was added to a mixture of 3 (3.78 mmol), 30% aqueous sodium hydroxide solution (18.9 mmol), and catalytic amount of hexadecyl trimethyl ammonium bromide (0.4 mmol) in 6 mL of CH 2 Cl 2 at room temperature. The reaction mixture was heated at reflux for 8 h. Subsequently, the mixture was diluted with water and extracted several times with dichloromethane. The combined organic phases were washed with brine, dried over MgSO 4 , and evaporated. The remainder was purified by chromatography on silica gel using petroleum ether (60-90 ∘ C) and ethyl acetate as the eluent to afford the title compounds 4a-4g. 
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